Self-medication of Ayurvedic Medicine Associated with Fatal Toxic Epidermal Necrolysis: A Case Report

Author:

Jangra Manjeet Singh1,Chhabra Manik2,Bhagavathula Akshaya Srikanth3

Affiliation:

1. Patient Safety Pharmacovigilance Associate, National Co-ordination Centre, PvPI, Indian Pharmacopoeia Commission, Ghaziabad UP, India

2. Department of Pharmacy Practice, ISF College of Pharmacy, Moga, Punjab, India

3. Department of Clinical Pharmacy, University of Gondar-College of Medicine and Health Sciences, Gondar, Ethiopia

Abstract

Introduction: Ayurveda is one of the most renowned traditional systems of medicine and is widely practiced in India. Self-medication of these ayurvedic medicines (AM’s) may elicit more or less similar type of adverse reactions as synthetic drugs. Methods: We present a case report on toxic epidermal necrolysis due to self-medication of ayurvedic medicine. Case Report: The present case is of a patient who used Singhnad Guggulu for 20 days and developed Steven-Johnson Syndrome (SJS) followed by toxic epidermal necrolysis (TEN). The patient was treated with steroids and antihistamines. The patient recovered completely following seven days of treatment and discharged. Results: After ruling out the provisional diagnosis, the patient was diagnosed with druginduced SJS/TEN. The World Health Organization-Uppsala Monitoring Center (WHOUMC) causality assessment scale was used by taking into consideration the temporal relationship and other relevant parameters and adverse drug reaction (ADR) was found to be ‘certain’. Conclusion: To our knowledge, the present case study is the first report of SJS/TEN that was caused by “Singhnad Guggulu” suggesting clinicians to be vigilant about the possibility of SJS/TEN occurrences with AM. Also, consumers should be advised to use these drugs only on the prescription of the institutionally qualified ayurvedic practitioners.

Publisher

Bentham Science Publishers Ltd.

Subject

Complementary and alternative medicine,Drug Discovery

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3